Skip to content

Insider · CIK 0001536967

Dolev Rafaeli

ceoofficerdirector

Files at SSKN (STRATA Skin Sciences, Inc.). First filing -, latest -.

In brief

Dolev Rafaeli files SEC Form 4 as CEO and director at SSKN (STRATA Skin Sciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Dolev Rafaeli has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 13, 2025SSKN
STRATA Skin Sciences, Inc.
AGrant or award
SSKN Stock Optionsderivative
+58,000$0.00$0232,557May 15, 2025
Oct 30, 2023SSKN
STRATA Skin Sciences, Inc.
AGrant or award
SSKN Stock Optionsderivative
+1,745,569$0.00$01,745,569Oct 30, 2023

Questions about Dolev Rafaeli

Answered from the filings on this page, as of the latest one.

Is Dolev Rafaeli buying or selling?

Dolev Rafaeli has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Dolev Rafaeli's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dolev Rafaeli has 0.

Where does Dolev Rafaeli file Form 4?

Dolev Rafaeli has filed Form 4 at SSKN (STRATA Skin Sciences, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dolev Rafaeli: insider trades and track record | InsiderTell